Tirzepatide 20mg (R&D Only) Tirzepatide research peptide, 20mg vial
The compound is not listed as a scheduled controlled substance under the international drug-control conventions or under the major national scheduling systems
The post warns that simultaneous use may create unpredictable metabolic stress or paradoxical responses, since nobody has studied what the two do together
Compare mechanisms, side effects, protocols & which is right for Canadians in 2026
The most common side effects are gastrointestinal: nausea, reduced appetite, mild stomach upset, occasional constipation or diarrhoea, especially as the dose is built up
The potential change appears to have put doctors largely at odds with the pharmacy compounding industry: at least one poll suggests 90% of physicians are worried about patients self-directed peptide use, while compounding pharmacies argue the change would give Americans a safer supply of drugs than what they are already using